Joincare Pharmaceutical Group Industry Co., Ltd

This study tested a new inhaled drug called JKN2304 in 42 people with moderate to severe COPD. The goal was to see if it is safe and helps improve lung function over 14 days. Participants received either JKN2304, a placebo, or an active comparator drug. The trial has been complet…

This early-stage study tested a single dose of an inhaled drug called DBM-1152A in 44 healthy Chinese adults. The main goal was to check if the drug is safe and how the body processes it. No treatment for any disease was involved, and participants were healthy volunteers.

This early-stage study tested a new drug called JKN2306 in 44 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it, including the effect of food. Since this was a phase 1 trial in healthy people, it does not provide any information…

This early-stage study tested the safety and how the body processes an inhaled drug called DBM-1152A in 20 healthy Chinese adults. Participants inhaled the drug or a placebo once daily for 7 days. The goal was to check for side effects and measure drug levels in the blood, not to…